HSIC

Henry Schein, Inc. HSIC

$87.82 -0.44 (-0.50%)

Extended · +1.75σ

+ Compare Open in Sniper

Mkt cap $9.8B

P/E 25.5

Day $87.31 – $88.94

52wk $68.70 – $89.34

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

Henry Schein, Inc. is a healthcare company listed in the US.

HSIC last traded at $87.82, down 0.5% on the day; that's in the upper part of its 52-week range ($68.70–$89.34). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $16.56 (fair range $17–$347); today's price sits 409% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$16.56

Fair-value range

$16.56 – $347.20

Margin of safety

-409%

Verdict

Overvalued

Accounting quality Weak

✓ Positive retained earnings

⚠ Debt exceeds cash
⚠ Quick ratio 0.55 (fragile)
⚠ Receivables growing faster than revenue
⚠ Inventory growing faster than revenue

Price implies ~22% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

HSIC is a $9.8 billion company, priced at 25× last year's earnings, and the stock is trading near the top of its 52-week range.

Mkt cap $9.8B

P/E ttm 25.5

Fwd P/E —

Beta —

Day range $87.31 – $88.94

52w range $68.70 – $89.34

Avg vol —

RSI(2) 65.0

ROE —

Net mgn —

FCF mgn 2.2%

Debt/Eq 0.78

Div yld —

Sector Healthcare

Industry Medical Distribution

Next earn —

52-week range · today's price

$68.70$89.34